NCT04740775

LiquiBand® Exceed™ and LiquiBand® Rapid™ for General Surgery Procedures

Clinical Study to Evaluate LiquiBand® Exceed™ and LiquiBand® Rapid™ for Closure of Surgical Incisions Associated With Abdominal Surgery

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 101 (actual)
• Sponsor: Advanced Medical Solutions Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this post market study is to evaluate the performance and safety of LiquiBand® Exceed™ and LiquiBand® Rapid™ for closure of surgical incisions associated with abdominal surgery.

Detailed description

LiquiBand® Exceed™ and LiquiBand® Rapid™ are the "study" devices. The study devices are an adhesive used to close surgical wounds. When the adhesive is applied to the skin, it polymerizes (forms a chemical bond) within minutes due to the moisture on the skin's surface and allows the wound edges to remain in the correct position. The use of the study devices are not "investigational" (experimental) because it is already cleared for doctors to use for surgical wound closure in the United States of America. In this study, LiquiBand® Exceed™ and LiquiBand® Rapid™ will be used to close surgical wounds following general abdominal surgery. Subjects will be followed up for 14-days post surgery, and safety and performance of the study device will be evaluated.

Conditions

• Surgical Wound

Interventions

Type	Name	Description
DEVICE	LiquiBand Exceed	Cyanoacrylate glue for closure of surgical wounds
DEVICE	LiquiBand Rapid	Cyanoacrylate glue for closure of surgical wounds

Timeline

• Start date: 2022-11-08
• Primary completion: 2024-03-19
• Completion: 2024-09-30
• First posted: 2021-02-05
• Last updated: 2025-01-28

Locations

4 sites across 1 country: United States

Regulatory

• FDA-regulated device study